Hepatocellular carcinoma in 2011: Genomics in hepatocellular carcinomag-a big step forward

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 2, 2012, Pages 69-70

  Tateishi, Ryosuke ^a   Omata, Masao ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b Yamanashi Prefectural Central Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I POLYPEPTIDE RELATED SEQUENCE A; MEMBRANE PROTEIN; SORAFENIB; UNCLASSIFIED DRUG;

ALCOHOLISM; ARID2 GENE; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER GROWTH; CANCER RISK; CHRONIC HEPATITIS; CTNNB1 GENE; DMXL1 GENE; DNA DAMAGE; DNA FLANKING REGION; GENE INSERTION SEQUENCE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NLP1 GENE; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; TUMOR SUPPRESSOR GENE;

CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOMICS; HUMANS; LIVER NEOPLASMS;

EID: 84856972935     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2011.255     Document Type: Review

References (9)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69-90 (2011).
2. Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N. Engl. J. Med. 348, 1625-1638 (2003). (Pubitemid 36459468)
3. Llovet, J. M. et al. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 359, 378-390 (2008).
4. Totoki, Y. et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat. Genet. 43, 464-469 (2011).
5. Li, M. et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat. Genet. 43, 828-829 (2011).
6. Kumar, V. et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat. Genet. 43, 455-458 (2011).
7. Miki, D. et al. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat. Genet. 43, 797-800 (2011).
8. International Cancer Genome Consortium. Dataset Summary. International Cancer Genome Consortium [online], http:// dcc.icgc.org/pages/summary/ (2011).
9. 1000 Genomes. About the 1000 Genomes Project. 1000 Genomes [online], http://1000genomes.org/page.php (2011).